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DOI 10.1186/s12882-015-0033-5RESEARCH ARTICLE Open AccessEffects of oxonic acid-induced hyperuricemia on
mesenteric artery tone and cardiac load in
experimental renal insufficiency
Venla Kurra1, Tuija Vehmas1, Arttu Eräranta1, Jarkko Jokihaara2, Päivi Pirttiniemi1, Heikki Ruskoaho3,4, Heikki Tokola3,5,
Onni Niemelä6, Jukka Mustonen1,7 and Ilkka Pörsti1,7*Abstract
Background: Recent studies suggest a causal role for increased plasma uric acid in the progression of chronic renal
insufficiency (CRI). However, uric acid also functions as an antioxidant with possible beneficial effects.
Methods: We investigated the influence of hyperuricemia on mesenteric arterial tone (main and second order
branch) and morphology in experimental CRI. Forty-four Sprague–Dawley rats were 5/6 nephrectomized (NX) or
Sham-operated and fed 2.0% oxonic acid or control diet for 9 weeks.
Results: Oxonic acid feeding elevated plasma uric acid levels 2.4 and 3.6-fold in the NX and Sham groups, respectively.
Plasma creatinine and urea were elevated 2-fold and blood pressure increased by 10 mmHg in NX rats, while hyperuricemia
did not significantly influence these variables. Right and left ventricular weight, and atrial and B-type natriuretic peptide
mRNA content were increased in NX rats, but were not affected by hyperuricemia. In the mesenteric artery, hyperuricemia
did not influence vasoconstrictor responses in vitro to norepinephrine or potassium chloride. The small arteries of NX rats
featured hypertrophic remodeling independent of uric acid levels: wall to lumen ratio, wall thickness and cross-sectional
area were increased without changes in lumen diameter. In the main branch, vasorelaxations to acetylcholine were
impaired in NX rats, but were not affected by hyperuricemia. In contrast, relaxations to the large-conductance Ca2+-activated
K+-channel (BKCa) opener NS-1619 were reduced by oxonic acid feeding, whereas responses to nitroprusside were not
affected.
Conclusions: Experimental hyperuricemia did not influence cardiac load or vascular remodeling, but impaired BKCa -mediated
vasorelaxation in experimental CRI.
Keywords: Uric acid, Artery tone, Experimental chronic renal insufficiency, 5/6 nephrectomy, Oxonic acidBackground
The prevalence of increased plasma uric acid (UA), hy-
peruricemia, is high in patients with chronic renal insuf-
ficiency (CRI). The detrimental effects of hyperuricemia
have been linked to cardiovascular complications, as
high plasma UA levels commonly predict the develop-
ment of hypertension [1] and the loss of renal function
[2]. To date, however, the contribution of UA to cardio-
vascular disease has still remained controversial [3].* Correspondence: ilkka.porsti@uta.fi
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unless otherwise stated.Previous experimental studies, carried out in rats made
hyperuricemic by the inhibition of the UA degrading en-
zyme uricase using dietary 2.0% oxonic acid, have sug-
gested a causal relationship between high UA and
cardiovascular disease [4-7]. UA has been associated
with stimulation of the renal renin-angiotensin system
(RAS) and reduced nitric oxide (NO) synthesis. These
mechanisms may have participated in the subsequent
hypertrophic remodeling of the preglomerular arteries,
tubulointerstitial damage, and thus predisposed to en-
hanced sodium retention [4-6,8]. Previously, incubation
of the rat aortic rings with UA was found to reduce
vasodilatation in response to acetylcholine (Ach) [9],
while the endothelial NO production in vitro washis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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the detrimental effects of hyperuricemia may partly re-
sult from endothelial dysfunction.
There is an ongoing debate about the role of UA in
vascular disease. This arises from the ability of UA to re-
duce oxidative stress by preventing the superoxide rad-
ical from reacting with NO to generate peroxynitrite
[11]. Peroxynitrite can impair NO-mediated relaxation
by inhibiting a critical cofactor of the endothelial NO
synthase [12], while it also can modulate vascular tone
via smooth muscle [13]. In the aortas of apolipoprotein
E-deficient mice, the ability of UA to reduce peroxyni-
trite levels was associated with improved Ach-elicited re-
laxation [12]. This result is in agreement with our earlier
report that oxonic acid-induced hyperuricemia improved
NO-mediated relaxation of the carotid artery in experi-
mental CRI by alleviating oxidative stress [14].
In experimental CRI, reduced vasodilatation via
Ca2+-activated K+-channels (BKCa), observed in isolated
mesenteric arterial branches, may precede the elevation
of blood pressure (BP) [15,16]. However, until now the
vascular effects of UA have only been studied in arteries
in which the endothelium-mediated dilatation is mainly
mediated via NO [12,14]. Here we examined the tone of
mesenteric arteries in vitro from the 5/6 nephrectomized
(NX) and Sham-operated rats allocated to 2.0% oxonic
acid diet for 9 weeks. Our findings suggest that oxonic
acid diet impaired relaxation via BKCa in arterial smooth
muscle, but did not significantly affect the endothelium-
dependent responses, resistance artery structure, or car-
diac load in experimental CRI.
Methods
Animals and experimental design
Male Sprague–Dawley rats (weight 335–341 g) were
housed in standard animal laboratory conditions with
free access to water and food pellets (Lactamin R34,
AnalyCen, Lindköping, Sweden) containing 0.9% cal-
cium, 0.8% phosphorus, 0.27% sodium, 0.2% magnesium,
0.6% potassium, 1500 IU/kg vitamin D and 12550 kJ/kg
energy, 16.5% protein, 4.0% fat, 58% nitrogen-free ex-
tract, 3.5% fiber, 6.0% ash, and 10% water. At the age of
8 weeks (study week 0), the rats were anesthetized with
ketamine/diazepam (75 and 2.5 mg/kg, intraperitoneally,
respectively) and NX (n = 22) was carried out by the re-
moval of upper and lower poles of the left kidney and
the whole right kidney. The sham-operation (n = 22) was
performed by kidney decapsulation as previously de-
scribed [15,17]. Antibiotics (metronidazole 60 mg/kg
and cefuroxim 225 mg/kg) and pain killers (buprenor-
phine 0.2 mg/kg subcutaneously) were given post-
operatively three times a day for the total duration of
three days. Three weeks after the surgery (study week 3,
i.e. preceding the treatments), the rats were divided intogroups (Sham, Sham+Oxo, NX, NX+Oxo) so that sys-
tolic BPs, body weights and urine volumes were similar
in the two Sham and two NX groups. Oxonic acid (Oxo;
20 g/kg chow, Sigma-Aldrich Chemical Co, St Louis, MO,
USA) was then added in the chow of the Sham+Oxo and
NX+Oxo groups, whereas the Sham and NX groups con-
tinued on the normal chow. Hyperuricemia was con-
firmed by tail vein sampling at study week 5, and 24-hour
urine was collected in metabolic cages at the end of the
2nd and 11th study weeks [14]. Before and during the
treatment period systolic BP was measured at 28°C by the
tail-cuff method as the averages of five recordings in each
rat (Model 129 Blood Pressure Meter; IITC Inc., Wood-
land Hills, CA, USA). The animals were kept in plastic re-
strainers during the measurements. To increase the
reliability, before the actual measurements the rats were
preconditioned on two separate occasions.
After 9 weeks of diets, the rats were weighed and
anesthetized (urethane 1.3 g/kg) and blood samples from
carotid artery for plasma creatinine, urea and UA were
drawn in to chilled tubes with EDTA and heparin as an-
ticoagulants. Blood samples from 2 rats in the Sham
group were lost due to technical problems. Plasma cre-
atinine and urea were measured using standard clinical
chemical methods (Cobas Integra 800 Clinical Chemical
Analyzer, Roche Diagnostics, Basel, Switzerland). UA
was measured using an enzymatic colorimetric method
[18]. The hearts and the kidneys were removed and
weighed. The ventricles were snap frozen in liquid
nitrogen-cooled isopentane and stored at −70°C until the
extraction of the total RNA. The experimental design of
the study was approved by the Animal Experimentation
Committee of the University of Tampere, Finland, and the
Provincial Government of Western Finland Department
of Social Affairs and Health, Finland. The investigation
conforms to the Guide for the Care and Use of Laboratory
Animals published by the US National Institutes of Health
(NIH Publication No. 85–23, revised 1996).
Functional responses and morphology of the mesenteric
arterial preparations in vitro
The experiments on isolated arteries were performed
from 10 randomly chosen rats in each group. Two suc-
cessive (3 mm in length) sections from the main branch
of superior mesenteric artery were excised beginning
3 mm distally from the mesenteric artery-aorta junction,
and small (1.9 mm in length) second order branches
were dissected from the mesenteric arterial bed under a
microscope (Nikon SMZ-2 T, Nikon Inc., Japan). The
endothelium was removed mechanically from the prox-
imal piece of the large artery and from one small arterial
ring by perfusing air through the lumen [15,17]. In the
distal piece of the main branch and in the other small
ring the endothelium was left intact. The large arterial
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mN/mm [16], while the small arterial preparations were
normalized so that the internal diameter of the vessel
was set at 90% of that obtained when exposed to intra-
luminal pressure of 100 mmHg in the relaxed state
[15,17]. In the large arteries, the force of contraction was
measured with isometric force-displacement transducer
and registered on a polygraph (FT 03 transducer, 7E
Polygraph; Grass Instrument Co., Quincy, MA, USA)
and in the small arteries the computerized Mulvany
multimyograph (Model 610A, J.P. Trading, Aarhus,
Denmark) was employed [16]. All arterial preparations
were kept in physiological salt solution (PSS, pH 7.4)
containing (mM): NaCl 119.0, NaHCO3 25.0, glucose
11.1, CaCl2 1.6, KCl 4.7, KH2PO4 1.2, MgSO4 1.2, and
aerated with 95% O2 and 5% CO2 at 37°C.
Contractions were cumulatively elicited in response to
norepinephrine (NE) and KCl in large and small arterial
rings. The main branch of the mesenteric artery was
chosen for the relaxation responses due to our extensive
previous experience with this model [19-22]. Vasodilata-
tion to Ach was investigated in endothelium-intact rings
after precontractions with 5 μM NE in the absence and
presence of the non-specific nitric oxide synthase (NOS)
inhibitor NG-nitro-L-arginine methyl ester (L-NAME,
0.1 mM). Responses to the NO donor sodium nitroprus-
side (NP) and BKCa opener NS-1619 were studied in
endothelium-denuded rings precontracted with KCl [23].
The efficiency of the removal of the endothelium was
confirmed by the lack of relaxation to Ach [22]. During
the experimental protocol, the rings were allowed a
30 min period at baseline tension in between each of the
concentration-response challenges.
Morphology of small arteries at 90 mmHg intraluminal
pressure was examined using a pressure myograph (Living
Systems Instrumentation, Inc., Burlington, VT, USA), as
previously reported [24]. The development of myogenic
tone was inhibited by Ca2+-free solution containing
30 mmol/L EDTA [25]. Small arteries were chosen for the
study of morphology due to their contribution to periph-
eral vascular resistance via remodeling [26].
Ventricular atrial and B-type natriuretic peptide, skeletal
α-actin and ß–myosin heavy chain mRNAs (ANP, BNP,
SkαA and β-MHC, respectively)
Total RNA was isolated from the ventricles by the guan-
idine thiocyanate CsCl method, and 20-μg samples of
RNA were transferred to nylon membranes (Osmonics)
for Northern blot analysis as described previously
[27,28]. Full-length rat ANP cDNA probe (a gift from
Dr. Peter Davies, Queen’s University, Kingston, Canada),
and cDNA probes for rat BNP, SkαA, ß-MHC and 18S
were prepared as previously reported [27,28]. The cDNA
probes were labeled, the membranes were hybridizedand washed, and exposed with PhosphorImager screens
(Amersham Biosciences), which were scanned with Mo-
lecular Imager FX Pro Plus and quantified using Quan-
tity One software (Bio-Rad) as previously described
[27,28]. The hybridization signals of specific mRNAs
were normalized to that of 18S RNA in each sample.
Data presentation and analysis of results
Contractile responses were expressed as maximal wall
tensions (mN/mm) and as a negative logarithm of the
agonist concentration producing 50% of maximal wall
tension (pD2). Relaxations were depicted as percentage of
pre-existing contraction. Statistical comparisons were car-
ried out using one-way and two-way analyses of variance
(ANOVA), and the Tukey test was used for post-hoc ana-
lyses (SPSS 17.0, SPSS Inc., Chicago, IL, USA). ANOVA for
repeated measurements was applied when data consisted of
repeated observations at successive observation points. The
results were expressed as mean ± SEM and P < 0.05 de-
noted statistical significance. Unless otherwise indicated,
the P values refer to one-way ANOVA.
Drugs
The drugs used in the present study were: ketamine
(Parke-Davis Scandinavia AB, Solna, Sweden), cefur-
oxim, diazepam (Orion Pharma Ltd., Espoo, Finland),
metronidazole (B. Braun AG, Melsungen, Germany),
buprenorphine (Reckitt & Colman, Hull, England), acetyl-
choline chloride, norepinephrine bitartrate, L-NAME
hydrochloride, NS-1619 (Sigma-Aldrich Chemical Co,
St Louis, MO, USA), sodium nitroprusside (Fluka Chemie
AG, Buchs SG, Switzerland). Stock solutions of the com-
pounds used in the functional arterial experiments were
made by dissolving the compounds in distilled water. So-
lutions were freshly prepared before use and protected
from light.
Results
Blood pressure, body weight, and heart weight
Systolic BP did not differ in the study groups at the begin-
ning of the oxonic acid diet (Table 1). At the end of the
study, mean systolic BP was higher in the two NX groups
versus Sham groups (P = 0.041, two-way ANOVA), and
concomitantly increased right and left ventricular weights
were also observed. Hyperuricemia did not influence BP
or ventricular weights, but was associated with lower final
body weight (P = 0.004, two-way ANOVA).
Laboratory findings
Plasma UA was 2.4-fold elevated in the Sham+Oxo and
3.6-fold elevated in the NX+Oxo rats when compared
with the corresponding controls (p = 0.005 and p = 0.002,
respectively), while subtotal renal ablation did not signifi-
cantly influence plasma UA levels (Table 1). Plasma
Table 1 Experimental group data (oxonic acid feeding period from week 3 to 12)
Sham Sham +Oxo NX NX + Oxo
Systolic blood pressure
Week 3 (before treatment) 119 ± 4 120 ± 5 128 ± 5 127 ± 5
Week 12 133 ± 7 135 ± 5 141 ± 6‡ 151 ± 5‡
Body weight (g)
Week 3 341 ± 6 337 ± 8 335 ± 8 331 ± 7
Week 12 436 ± 9 411 ± 12# 452 ± 11 412 ± 30#
Heart weight (g/kg) at the end of study
Right ventricle 0.28 ± 0.01 0.29 ± 0.01 0.34 ± 0.03‡ 0.33 ± 0.03‡
Left ventricle 1.71 ± 0.06 1.86 ± 0.06 2.23 ± 0.11*‡ 2.41 ± 0.18*‡
Removed kidney tissue (g/kg) 7.67 ± 0.17 7.50 ± 0.08
Uric acid (μmol/l) 33.5 ± 11.8 121.6 ± 22.4* 64.4 ± 21.0 156.7 ± 20.2*†
Creatinine (μmol/l) 40.1 ± 5.7 49.3 ± 3.2 80.7 ± 3.2*‡ 81.8 ± 8.8*‡
Urea (mmol/l) 6.5 ± 0.4 8.3 ± 0.5 12.9 ± 0.6*‡ 14.3 ± 2.2*‡
Values are mean ± SEM; n = 11, except for laboratory values in the Sham group n = 9. *P < 0.05 compared with the Sham group, †P < 0.05 compared with the NX
group using one-way ANOVA; ‡P < 0.05 NX groups compared with the Sham groups using two-way ANOVA; #P < 0.05 Sham+Oxo and NX+Oxo groups compared
with the Sham and NX groups using two-way ANOVA.
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two-fold in the NX groups and were not affected by
hyperuricemia.
Ventricular load, as evaluated using ANP, BNP, SkαA and
β-MHC mRNA levels
The synthesis of right and left ventricular ANP and BNP
mRNAs, and left ventricular SkαA and β-MHC mRNAs,
were clearly higher in the NX groups when compared
with the Sham groups (P < 0.05 for all, two-way
ANOVA) (Figure 1). Oxonic acid feeding did not influ-
ence the mRNA levels of these genes.
Functional responses in the main branch of the
mesenteric artery
Contractile sensitivity to NE was slightly higher in the
NX groups when compared with the two Sham groups
(P < 0.001, two-way ANOVA). However, the difference in
the contractions to NE did not curtail the results on va-
sorelaxation, as the relaxations were elicited after 5 μM
NE concentration that induced approximately 70-80% of
maximal response in all groups. Responses to KCl were
comparable between NX and Sham rats. The relaxation
induced by Ach in the main branch of the mesenteric ar-
tery was markedly impaired in the NX groups, while ex-
perimental hyperuricemia did not influence these
responses either in Sham or NX rats (P = 0.208 NX ver-
sus NX+Oxo groups, ANOVA for repeated measure-
ments) (Figure 2A). Inhibition of NOS with L-NAME
equally reduced the relaxation to Ach in the Sham and
Sham+Oxo groups, while the response was almost abol-
ished in the NX and NX+Oxo groups (Figure 2B). As
displayed by the diminished relaxation to NP,vasorelaxation via cGMP in arterial smooth muscle was
reduced in the NX groups when compared with the
Sham groups (P = 0.008, two-way ANOVA for repeated
measurements), whereas oxonic acid feeding did not in-
fluence this response (Figure 2C). In contrast, vasorelax-
ation induced by the BKCa opener NS-1619 was
significantly reduced in NX+Oxo rats when compared
with all other groups (P = 0.032, ANOVA for repeated
measurements) (Figure 2D).
Functional responses and morphology of the small
mesenteric artery
In the small arterial rings, maximal wall tension in re-
sponse to NE was higher in the NX rats than in Sham
rats (P = 0.03, two-way ANOVA), while the sensitivity to
NE (pD2) was similar in all groups (Table 2). Responses
to KCl were comparable between NX and Sham rats also
in the small mesenteric artery. Isolated second order
mesenteric artery branches from NX rats exhibited hyper-
trophic remodeling: increased wall thickness, wall to
lumen ratio, and wall cross-sectional area without changes
in lumen diameter when compared with Sham rats. Ex-
perimental hyperuricemia did not significantly influence
the structure of small mesenteric artery (Figure 3).
Discussion
Oxonic acid-induced hyperuricemia has been widely
studied in recent years, but consensus on the putative
harmfulness of increased circulating UA concentration
still remains elusive. In this study we employed the 5/6
nephrectomy rat model of CRI to investigate the influ-
ence of experimental hyperuricemia on the tone and
morphology of the mesenteric artery. The NX rats showed
Figure 1 Evaluation of cardiac load. Right ventricular atrial natriuretic peptide (ANP) (A) and B-type natriuretic peptide (BNP) (B); and left ventricular
ANP (C), BNP (D), skeletal α-actin (SkαA) (E), and β-myosin heavy chain (β-MHC) (F) mRNAs in the experimental groups; values are mean±SEM, n = 11
for all groups; *P < 0.05, two-way ANOVA compared with the Sham groups. NX=5/6 nephrectomized rat, Sham=sham-operated rat, Oxo=2.0% oxonic
acid diet.
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ciency [16,29], whereas experimental hyperuricemia did
not influence vasoconstrictor responses, renal function,
cardiac load, or small artery morphology. To our know-
ledge, the present study is the first to suggest that hyper-
uricemia may impair vasorelaxation via BKCa, indicating
alteration in smooth muscle hyperpolarization.
Oxonic acid feeding inhibits the oxidation of UA to its
metabolite, allantoin, resulting in hyperuricemia. In the
present study, oxonic acid diet elevated plasma UA 2.4
to 3.6-fold, which is in line with the 1.3 to 2.8-fold eleva-
tions observed in previous experimental studies [4-6].
The development of stage 2–3 renal insufficiency was
confirmed by the elevated levels of plasma creatinine andurea, impaired endothelium-mediated vasodilatation,
hypertrophic remodeling of the resistance vessels, and
modest elevation of BP [15,29]. Increased right and left
ventricular weights, higher ANP and BNP mRNA content,
as well as increased left ventricular SkαA and β-MHC
mRNA content, indicated permanent volume and pres-
sure overload after subtotal renal ablation [15]. However,
hyperuricemia did not significantly influence any of the in-
dicators of cardiac load either in the Sham or NX rats.
Arterial contractions were examined here in order to
reveal differences in vasoconstrictor sensitivity that
would potentially interfere with the interpretation of the
relaxation experiments. No differences were found in re-
sponses elicited by membrane depolarisation with KCl
Figure 2 Vasorelaxation in vitro. Line graphs show relaxation responses induced by acetylcholine in the absence (A) and presence (B) of L-NAME,
and relaxations elicited by the NO donor nitroprusside (C), and the large conductance calcium-activated potassium channel opener NS-1619 (D) in the
experimental groups; values are mean ± SEM, n = 10 for all groups; *P < 0.05, ANOVA for repeated measurements; †P < 0.05 NX groups compared with
the Sham groups using two-way ANOVA for repeated measurements. Groups as in Figure 1.
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higher sensitivity but no significant change in maximal
response to NE. However, in the small artery the NX
groups exhibited slightly higher maximal response with-
out changes in sensitivity to NE. Importantly, oxonic
acid feeding did not influence the vasoconstrictor re-
sponses either in the second order or main branches of
the mesenteric artery. Thus, changes in the vasodilator
responses induced by hyperuricemia were not explained
by alterations in vasoconstrictor responses.
Oxonic acid feeding did not induce changes in the
morphology of small mesenteric arteries, while hyper-
trophic arterial remodeling was clearly observed in the
NX rats [15]. Previously, oxonic acid diet was found to
activate renal RAS, as indicated by increased expression
of juxtaglomerular renin, and result in hypertrophic re-
modeling of the glomerular afferent arterioles [5-7,30].
Although local vascular RAS components were not ex-
amined here, the oxonic acid model of hyperuricemia is
characterized by elevated plasma levels of aldosteronewith subsequent sodium retention [8]. The present re-
sults suggest that despite possible activation of the circu-
lating RAS, high UA level does not influence the
morphology of small arteries and heart.
Vasorelaxation was investigated in the main branch of
the mesenteric artery, which functionally resembles the
second-order branches in the same arterial bed [15,16].
Unlike the rat aorta, where endothelium-dependent
vasodilatation is largely mediated via NO, the endothelium-
derived relaxation of the mesenteric artery is also mediated
by hyperpolarization of smooth muscle [15]. Relaxation to
Ach was impaired in NX rats, and the response was prac-
tically abolished in the presence of L-NAME in both NX
groups, indicating that it was mediated via NO. Inhibition
of NOS reduced the relaxation to Ach also in Sham rats,
but the vessels showed more pronounced relaxations in
the presence of L-NAME than those from NX rats
[15,16]. The L-NAME resistant vasorelaxation in the rat
mesenteric artery has been attributed to endothelium-
dependent hyperpolarization [15-17]. In Sham and NX
Table 2 Parameters of contractile responses of isolated second order branches and the main branch of the mesenteric
artery
Sham Sham+Oxo NX NX+Oxo
Small artery
Norepinephrine
pD2 (−log mol/l) 5.81 ± 0.08 6.00 ± 0.09 5.81 ± 0.09 5.87 ± 0.11
Maximal wall tension (mN/mm) 5.46 ± 0.17 5.82 ± 0.50 6.63 ± 0.54‡ 6.58 ± 0.39‡
KCl
pD2 (−log mol/l) 1.41 ± 0.01 1.42 ± 0.02 1.39 ± 0.02 1.39 ± 0.03
Maximal wall tension (mN/mm) 5.59 ± 0.43 5.93 ± 0.56 6.37 ± 0.49 6.84 ± 0.32
Main branch
Norepinephrine
pD2 (−log mol/l) 6.26 ± 0.14 5.97 ± 0.05 6.49 ± 0.13
‡ 6.64 ± 0.11‡
Maximal wall tension (mN/mm) 7.30 ± 0.49 8.60 ± 0.49 9.14 ± 0.63 9.64 ± 1.52
KCl
pD2 (−log mol/l) 1.51 ± 0.02 1.51 ± 0.03 1.51 ± 0.03 1.53 ± 0.03
Maximal wall tension (mN/mm) 6.79 ± 0.85 7.01 ± 0.94 7.53 ± 0.67 8.02 ± 0.96
Values are mean ± SEM, n = 10 for all groups. pD2 is the negative logarithm of the concentration of agonist producing 50% of the maximal response.
‡P < 0.05 NX
groups compared with Sham groups using two-way ANOVA.
Figure 3 Arterial morphology. Small artery wall thickness (μm) (A), lumen diameter (μm) (B), wall to lumen ratio (%) (C), and wall area (μm2) (D)
at 90 mmHg; values are mean ± SEM, n = 10 for all groups; *P < 0.05 versus Sham. Groups as in Figure 1.
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the response to Ach, indicating that endothelium-
dependent relaxation was not affected by oxonic acid
feeding. Vasorelaxation to the exogenous NO donor NP
was slightly impaired in the NX groups when compared
with the Sham groups, but hyperuricemia did not influ-
ence the sensitivity of arterial smooth muscle to relaxation
via cGMP.
The present study showed that the endothelium-
independent vasodilatation induced by the BKCa channel
opener NS-1619 was impaired in the NX+Oxo group.
Notably, this impairment was not observed in Sham+Oxo
rats. NS-1619 induces relaxation by triggering intracellular
Ca2+ sparks, which induce K+-efflux via BKCa and lead to
subsequent hyperpolarization [31-33]. The finding of de-
creased vasorelaxation sensitivity via BKCa solely in the
hyperuricemic NX rats suggests that the effect was specif-
ically associated with the combination of uremic milieu
and increased plasma UA concentration.
Several mechanisms could result in alterations of BKCa
mediated vascular tone. The BKCa channel, which consists
of α- and β1-subunits, is the most prominent type of
calcium-activated K+ channel in arterial smooth muscle
[13]. The β1-subunit is responsible for tuning the
Ca2+-sensitivity [34]. Interaction between the α-subunit
and β1-subunit enhances Ca2+-sensitivity of BKCa chan-
nels, whereas the loss of the β1-subunit decreases Ca2+
sensitivity [35]. In a recent study using diabetic mice [36],
BKCa expression in arterial myocytes was strongly influ-
enced by the calcineurin pathway, which inhibits the
expression of the regulatory β1-subunit.
Endogenous BKCa inhibitors may influence K
+-channel
activity. Arachidonic acid metabolites, especially 20-
hydroxyeicosatetraenoic acid (20-HETE), can inhibit BKCa
[37]. 20-HETE reduces the open-state probability of the
channel [38]. Another endogenous inhibitor of BKCa is
hydrogen sulfide, which binds to the α-subunit and in-
creases the voltage needed for channel activation [39].
BKCa are also modulated by reactive oxidative species
(ROS), which can activate or inactivate BKCa [13]. Such
mechanisms are relevant, as elevated UA level following
2.0% oxonic acid feeding has increased total peroxyl
radical-trapping capacity and reduced oxidative stress
markers in the rat [14]. Hyperuricemia may increase
superoxide dismutase (SOD) activity [40], which catalyzes
the dismutation of superoxide (O2
−) into oxygen and
hydrogen peroxide (H2O2). UA itself is able to scavenge
BKCa-inhibiting radicals, and increase the production of
H2O2 by preventing the H2O2-induced inactivation of
SOD [40]. H2O2 can even induce vasodilatation directly
via BKCa activation [41], an effect known to be more pro-
nounced under conditions of reduced NO availability [13].
The latter is a characteristic feature of the uremic milieu
[42]. Taken together, a multitude of processes caninfluence vasorelaxation via BKCa, including changes in
channel protein gene expression and structure, changes in
cellular Ca2+ sparks, levels of ROS, and endogenous BKCa
inhibitors.
UA is produced from xanthine by the enzyme xantine
oxidase, which has been found to play an important role
in a variety of tissue and vascular injuries [43]. Although
therapeutic interventions with the aim to lower UA with
xanthine oxidase inhibitors may be beneficial in treating
the vascular disorders associated with renal disease, debate
is still ongoing whether the effect is related to lowering
UA levels per se, or to reduced xanthine oxidase activity.
The present protocol did not include the treatment of hy-
peruricemia, since the UA-lowering drugs allopurinol,
febuxostat and uricosuric agents have been well docu-
mented to prevent the pathophysiological changes in-
duced by the oxonic acid feeding [4-6,10,30,44-46].
Conclusions
We show here that 2.0% oxonic acid diet increased
plasma UA, but did not significantly influence BP, resist-
ance vessel structure, and cardiac load as evidenced by
the unaltered ventricular weights and mRNA levels of
natriuretic peptides, SkαA, and β-MHC. Hyperuricemia
did not influence endothelium-dependent NO-mediated
vasorelaxation, but oxonic acid feeding impaired vasore-
laxation elicited by the BKCa channel opener NS-1619 in
this model of CRI. Future studies are needed to define
the molecular mechanisms by which hyperuricemia can
influence BKCa function in experimental CRI.
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